BlackRock
BNTX icon

BlackRock’s BioNTech BNTX Stock Holding History

BlackRock’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173M Buy
1,854,966
+196,813
+12% +$18.5M ﹤0.01% 1890
2026
Q1 		$147M Buy
1,658,153
+505,269
+44% +$51.9M ﹤0.01% 1863
2025
Q4 		$110M Buy
1,152,884
+387,575
+51% +$39M ﹤0.01% 2056
2025
Q3 		$75.5M Sell
765,309
-548,718
-42% -$58.7M ﹤0.01% 2258
2025
Q2 		$140M Sell
1,314,027
-351,912
-21% -$35.5M ﹤0.01% 1836
2025
Q1 		$152M Sell
1,665,939
-190,473
-10% -$21.3M ﹤0.01% 1748
2024
Q4 		$212M Sell
1,856,412
-215,522
-10% -$24.6M ﹤0.01% 1650
2024
Q3 		$246M Buy
2,071,934
+176,507
+9% +$16.2M 0.01% 1534
2024
Q2 		$152M Sell
1,895,427
-11,414
-0.6% -$1.04M ﹤0.01% 1777
2024
Q1 		$176M Buy
1,906,841
+266,825
+16% +$25.6M ﹤0.01% 1731
2023
Q4 		$173M Buy
1,640,016
+66,205
+4% +$6.67M ﹤0.01% 1739
2023
Q3 		$171M Sell
1,573,811
-157,279
-9% -$17.4M ﹤0.01% 1643
2023
Q2 		$187M Sell
1,731,090
-194,708
-10% -$21.9M 0.01% 1628
2023
Q1 		$240M Sell
1,925,798
-132,725
-6% -$18.2M 0.01% 1421
2022
Q4 		$309M Buy
2,058,523
+545,623
+36% +$84M 0.01% 1218
2022
Q3 		$204M Sell
1,512,900
-99,483
-6% -$15.2M 0.01% 1459
2022
Q2 		$240M Buy
1,612,383
+1,408
+0.1% +$215K 0.01% 1386
2022
Q1 		$275M Buy
1,610,975
+331,101
+26% +$55.6M 0.01% 1435
2021
Q4 		$330M Sell
1,279,874
-194,235
-13% -$53.2M 0.01% 1356
2021
Q3 		$402M Sell
1,474,109
-7,281
-0.5% -$2.31M 0.01% 1160
2021
Q2 		$332M Buy
1,481,390
+738,532
+99% +$139M 0.01% 1385
2021
Q1 		$81.1M Buy
742,858
+74,312
+11% +$7.89M ﹤0.01% 2308
2020
Q4 		$54.5M Buy
668,546
+657,872
+6,163% +$64.6M ﹤0.01% 2419
2020
Q3 		$739K Buy
10,674
+2,284
+27% +$164K ﹤0.01% 4186
2020
Q2 		$560K Sell
8,390
-3,051
-27% -$152K ﹤0.01% 4182
2020
Q1 		$668K Buy
11,441
+569
+5% +$22.1K ﹤0.01% 3988
2019
Q4 		$368K Buy
+10,872
New +$244K ﹤0.01% 4217

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

BlackRock's BNTX Position: Q2 2026 in Review

BlackRock increased its BioNTech (BNTX) stake by 12% in Q2 2026, buying an estimated $18.5M and bringing the position to 1,854,966 shares worth $173M. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

BlackRock first reported a position in BNTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $402M in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • BlackRock held 1,854,966 shares of BioNTech worth $173M as of Q2 2026.
  • BlackRock bought 196,813 BioNTech shares in Q2 2026, an estimated $18.5M.
  • BioNTech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1890 holding.
  • BlackRock first reported a position in BioNTech in Q4 2019 and has held it in 27 quarters since.
  • BlackRock's BioNTech position peaked at $402M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.